News
The Biggest Problem With Chipotle's Latest Outbreak Isn't What You Think
Chipotle Mexican Grill, Inc. (NYSE: CMG) may be living its nightmare all over again. Shares of the burrito chain were down as much as 7.6% on news that a Chipotle location in Virginia had shut down in
Better Buy: Celldex Therapeutics, Inc. vs. Juno Therapeutics
Celldex Therapeutics (NASDAQ: CLDX) and Juno Therapeutics (NASDAQ: JUNO) are both once-promising clinical-stage biotechs that have fallen on extremely hard times of late. Over the past two and half
3 Automakers Poised to Benefit From Self-Driving Cars (and They're Not Who You Might Think)
For investors looking to profit from the nascent field of self-driving cars, the amount of information available is mind-boggling. Market-intelligence company CB Insights has identified a whopping 44
Imposter Syndrome: How to Stop This Debilitating Idea in Its Tracks
At some point, nearly every successful person is in a position where they feel like they don't belong.Perhaps you have to speak at a meeting being attended by senior leadership at your company or even
Video: Schnäppchenjäger: Dax startet leicht erholt in den Handel
Das niedrigere Kursniveau lockt heute Morgen einige Anleger an den deutschen Aktienmarkt. Der Dax startet mit 12.468 Punkten 0,3 Prozent fester. Der Euro gibt leicht nach und notiert bei 1,1525....
10 Companies That Apple Doesn't Have Enough Cash to Buy
Image source: Apple.With a market cap of about $784.5 billion, Apple (NASDAQ: AAPL) is by far the most valuable company in the world. A lot of that value, however, is tied up in cash -- most of which
5 Things About Social Security Everyone Should Know
Image source: Getty Images.If you're a long way from retirement, knowing the ins and outs of Social Security might not seem particularly important. However, your Social Security benefits should play a
3 Stocks That Look Today Like Activision Blizzard Did in 2014
Investors in Activision Blizzard (NASDAQ: ATVI) have enjoyed market-thumping returns over the last few years. The video game maker's shares have appreciated 236% since the start of 2014 alone, thanks
Shopify Is Turning Another Competitor Into a Partner
Shopify (NYSE: SHOP) sells a software package that helps small businesses open online storefronts. At that most basic level, it competes with eBay (NASDAQ: EBAY) and Amazon (NASDAQ: AMZN), which also
Arcelor – Comeback des Stahlriesen!
Der Stahlhersteller ArcelorMittal ist zurück auf Wachstumskurs. Das suggerieren jedenfalls die Zahlen zum ersten Quartal des laufenden Geschäftsjahres. So profitierte der Konzern sowohl von....
Liebe Börseneinmaleins Leserinnen und Leser
die Freebie Aktion unter uns Finanzbloggern war ein voller Erfolg. Über eine Woche lang konnte man sich auf www.finanzblog-magazin.de verschiedene kostenlose Tools von neun verschiedenen Bloggern....
Energiewende
Endergiewende 2.0?
Seit dem offiziellen Start der Energiewende in Deutschland (nach der Atomkatastrophe in Fukushima) gab es schon einige staatlich vorgeschriebene Änderungen. Eine der....
Was ist... Buy & Hold?
Buy & Hold ist eine Anlagestrategie, die darauf abzielt, Wertpapiere langfristig zu halten. Hierdurch wird das Risiko durch die Schwankungen an den Märkten gesenkt und die Erfolgsaussicht auf....
SES-IMAGOTAG : Signing of the share purchase agreement relating to the acquisition of a majority stake in SES-imagotag by BOE Technology Group Co., Ltd.
Following the announcement on 16 June 2017 of the entry into exclusive negotiations between the main shareholders of SES-imagotag and BOE Technology Group Co., Ltd. (“BOE”) and after the....
SES-IMAGOTAG : Signature du contrat d'acquisition relatif à l'achat par BOE Technology Group d'une participation majoritaire dans SES-imagotag
Faisant suite à l'annonce, le 16 juin, de l'entrée en négociations exclusives des principaux actionnaires de SES-imagotag avec le groupe BOE Technology (« BOE ») et après consultation des....
Citigroup sieht weiteres Potential für die Commerzbank
Kräftig aufwärts ging es bereits in den letzten Monaten bei den Aktien der Commerzbank. Von Jahrestiefstständen bei Kursen um die 7 Euro haben sich die Papiere inzwischen kräftig erholt und....
Sierra Metals stellt die Weichen für zukünftige Produktionssteigerungen
Der kanadische Edel- und Basismetallproduzent Sierra Metals (ISIN: CA82639W1068 / TSX: SMT) musste im abgelaufenen Quartal gegenüber dem zweiten Vorjahresquartal eine 3 % niedrigere Metallproduktion
CSX Picks Up Steam, but Will New Initiatives Produce More Growth?
Railroad companies have worked hard to try to claw their way back from tough times over the past two years. CSX (NASDAQ: CSX) in particular has focused on restructuring efforts designed to increase
EnWave kooperiert mit Nestlé und schließt weitere Lizenzabkommen ab
Wie der kanadische Nahrungsmittel-Spezialist EnWave (ISIN: CA29410K1084 / TSX-V:ENW) vergangene Woche mitteilte hat man mit Nestec, einer Tochtergesellschaft der Nestlé S.A. aus der Schweiz, den
Is Microsoft's Xbox One X a Game-Changer?
After much anticipation, Microsoft (NASDAQ: MSFT) finally unveiled Xbox One X at the Woodstock for gamers (aka E3 2017) in Los Angeles in June. Xbox One X is a beast of a console, and it's also the
Honda Confronts a Shrinking Sedan Market With All-New 2018 Accord
Honda (NYSE: HMC) last week took the wraps off of its all-new 2018 Accord sedan. It's the 10th generation of the car that has arguably been Honda's most important product in the U.S. for many years.
What Are Bear Funds?
Most investors focus on owning stocks with the expectation that they'll rise in value. During bull markets, that strategy works very well. When bear markets strike, however, owning stocks is often
Intel Corporation May Have a "Gap" in Its Desktop Processor Lineup in 2018
Former Intel (NASDAQ: INTC) executive Kirk Skaugen, who used to lead the company's client computing group, admitted to making a serious mistake with respect to its roughly $10 billion desktop
Does Puma Biotechnology's Approval Make It Worth More?
Puma Biotechnology's (NASDAQ: PBYI) roller-coaster ride to approval is finally over. After fits and starts in clinical trials, the FDA gave the company's breast cancer drug, Nerlynx, a green light
This Is Blue Apron's Biggest Problem
As far as initial public offerings go, something close to the worst-case scenario is playing out for meal-kit delivery company Blue Apron (NYSE: APRN). Originally expected to price its shares between